Aster DM Healthcare (ASTERDM) | Financial Analysis & Statements
Aster DM Healthcare Ltd. Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
10.8B
Gross Profit
8.3B
77.07%
Operating Income
1.4B
13.37%
Net Income
935.6M
8.68%
EPS (Diluted)
₹1.67
Balance Sheet Metrics
Total Assets
66.1B
Total Liabilities
29.5B
Shareholders Equity
36.5B
Debt to Equity
0.81
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Aster DM Healthcare Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 40.7B | 36.4B | 29.5B | 102.5B | 85.2B |
| Cost of Goods Sold | 9.4B | 9.2B | 7.8B | 28.9B | 25.7B |
| Gross Profit | 31.3B | 27.3B | 21.7B | 73.6B | 59.5B |
| Gross Margin % | 76.9% | 74.9% | 73.4% | 71.8% | 69.8% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 11.1B | 9.9B | 7.7B | 8.1B | 8.4B |
| Other Operating Expenses | 4.9B | 4.7B | 4.1B | 18.0B | 12.4B |
| Total Operating Expenses | 16.1B | 14.6B | 11.8B | 26.1B | 20.8B |
| Operating Income | 5.3B | 3.7B | 2.7B | 8.4B | 5.0B |
| Operating Margin % | 12.9% | 10.1% | 9.0% | 8.2% | 5.9% |
| Non-Operating Items | |||||
| Interest Income | 1.1B | 47.8M | 48.6M | 48.0M | 42.0M |
| Interest Expense | 1.1B | 1.1B | 851.5M | 2.6B | 2.9B |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 4.7B | 2.6B | 2.0B | 6.4B | 2.1B |
| Income Tax | 1.3B | 565.1M | 358.7M | 358.0M | 272.2M |
| Effective Tax Rate % | 28.5% | 21.6% | 18.4% | 5.6% | 13.3% |
| Net Income | 54.1B | 2.1B | 4.8B | 6.0B | 1.8B |
| Net Margin % | 132.9% | 5.8% | 16.1% | 5.9% | 2.1% |
| Key Metrics | |||||
| EBITDA | 8.7B | 13.5B | 10.6B | 15.3B | 11.3B |
| EPS (Basic) | ₹107.98 | ₹2.60 | ₹8.54 | ₹10.58 | ₹2.97 |
| EPS (Diluted) | ₹107.85 | ₹2.60 | ₹8.53 | ₹10.57 | ₹2.97 |
| Basic Shares Outstanding | 498000000 | 497500000 | 497300000 | 497155009 | 496900000 |
| Diluted Shares Outstanding | 498000000 | 497500000 | 497300000 | 497155009 | 496900000 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Aster DM Healthcare Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 1.6B | 822.3M | 3.8B | 3.4B | 2.6B |
| Short-term Investments | 12.0B | 283.4M | 589.9M | 780.6M | 565.3M |
| Accounts Receivable | 2.6B | 2.3B | 23.4B | 20.2B | 20.2B |
| Inventory | 923.5M | 1.1B | 13.1B | 10.3B | 8.5B |
| Other Current Assets | 8.6M | 31.7M | 2.9B | 5.0B | 3.5B |
| Total Current Assets | 19.0B | 141.7B | 49.2B | 41.0B | 36.3B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 12.7B | 11.5B | 22.9B | 19.7B | 18.4B |
| Goodwill | 5.6B | 5.6B | 26.9B | 24.5B | 23.5B |
| Intangible Assets | 303.2M | 313.7M | 3.7B | 2.8B | 2.5B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 571.1M | 500.0K | 1.1B | 746.2M | 352.2M |
| Total Non-Current Assets | 47.0B | 38.3B | 99.6B | 84.5B | 80.1B |
| Total Assets | 66.1B | 179.9B | 148.8B | 125.5B | 116.4B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 4.3B | 4.6B | 29.9B | 21.2B | 20.3B |
| Short-term Debt | 1.9B | 2.5B | 12.3B | 9.7B | 7.7B |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 24.1M | 18.5M | 138.6M | 201.8M | 109.5M |
| Total Current Liabilities | 8.8B | 112.9B | 46.6B | 35.6B | 32.0B |
| Non-Current Liabilities | |||||
| Long-term Debt | 18.3B | 11.4B | 44.7B | 39.4B | 40.3B |
| Deferred Tax Liabilities | 1.5B | 2.5B | 2.4B | 1.7B | 1.5B |
| Other Non-Current Liabilities | 525.7M | 491.0M | 6.2M | 261.9M | 302.4M |
| Total Non-Current Liabilities | 20.8B | 16.7B | 53.7B | 45.1B | 46.1B |
| Total Liabilities | 29.5B | 129.6B | 100.2B | 80.6B | 78.1B |
| Equity | |||||
| Common Stock | 5.0B | 5.0B | 5.0B | 5.0B | 5.0B |
| Retained Earnings | -1.5B | 4.9B | 4.2B | 4.1B | -990.6M |
| Treasury Stock | 82.3M | 109.7M | 134.9M | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 36.5B | 50.3B | 48.6B | 44.8B | 38.3B |
| Key Metrics | |||||
| Total Debt | 20.2B | 13.8B | 57.0B | 49.1B | 48.0B |
| Working Capital | 10.2B | 28.8B | 2.7B | 5.4B | 4.3B |
Balance Sheet Composition
Aster DM Healthcare Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 55.4B | 3.3B | 5.4B | 6.4B | 2.1B |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | 84.2M | 73.6M | 6.7M | -1.3M | 24.9M |
| Working Capital Changes | -1.4B | -16.7B | 878.8M | -4.0B | 2.0B |
| Operating Cash Flow | 54.1B | -9.3B | 9.5B | 4.9B | 6.9B |
| Investing Activities | |||||
| Capital Expenditures | -3.4B | -7.5B | -7.1B | -4.8B | -3.7B |
| Acquisitions | 75.6B | -1.4B | -1.3B | -472.6M | 654.1M |
| Investment Purchases | -11.9B | - | -46.1M | - | -125.3M |
| Investment Sales | 84.6M | 82.1M | 3.1M | 174.9M | - |
| Investing Cash Flow | 60.3B | -8.8B | -8.4B | -5.1B | -3.1B |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -61.7B | - | - | - | - |
| Debt Issuance | 1.9B | - | 3.6B | 673.8M | 1.9B |
| Debt Repayment | -1.3B | - | -6.0B | -3.7B | -5.6B |
| Financing Cash Flow | -61.8B | 2.5B | -2.0B | -2.1B | -6.2B |
| Free Cash Flow | 683.2M | -6.5B | 9.9B | 7.7B | 11.5B |
| Net Change in Cash | 52.6B | -15.6B | -884.1M | -2.3B | -2.4B |
Cash Flow Trend
Aster DM Healthcare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
110.37
Forward P/E
60.80
Price to Book
8.03
Price to Sales
8.17
PEG Ratio
-2.33
Profitability Ratios
Profit Margin
7.33%
Operating Margin
12.11%
Return on Equity
147.28%
Return on Assets
81.40%
Financial Health
Current Ratio
2.16
Debt to Equity
43.79
Beta
-0.06
Per Share Data
EPS (TTM)
₹6.39
Book Value per Share
₹87.77
Revenue per Share
₹87.42
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ASTERDM | 364.6B | 110.37 | 8.03 | 147.28% | 7.33% | 43.79 |
| Apollo Hospitals | 1.1T | 61.08 | 12.11 | 16.71% | 7.44% | 83.61 |
| Max Healthcare | 979.8B | 68.81 | 9.77 | 11.47% | 17.43% | 32.58 |
| Fortis Healthcare | 699.7B | 72.46 | 7.40 | 8.44% | 10.94% | 32.96 |
| Narayana Hrudayalaya | 365.2B | 46.80 | 8.99 | 21.78% | 11.49% | 57.61 |
| Global Health | 298.6B | 58.23 | 8.08 | 14.21% | 12.29% | 25.47 |
Financial data is updated regularly. All figures are in the company's reporting currency.





